吸烟、HbA1c、PLT、GLB、CK-MB与2型糖尿病合并冠心病冠脉狭窄的相关性研究
A Study on the Correlation between Smoking, HbA1c, PLT, GLB, CK-MB and Coronary Stenosis in Type 2 Diabetes Mellitus Patients with Coronary Heart Disease
DOI: 10.12677/acm.2025.15102769, PDF,   
作者: 聂梦梦:安徽医科大学第一附属医院全科医学科,安徽 合肥;张 勇*:安徽医科大学第一附属医院心血管内科,安徽 合肥
关键词: 冠心病2型糖尿病冠状动脉狭窄影响因素Coronary Heart Disease Type 2 Diabetes Mellitus Coronary Atherosclerotic Stenosis Factors
摘要: 目的:早期识别2型糖尿病合并冠心病患者冠状动脉狭窄程度的潜在影响因素,以优化预后治疗策略。方法:回顾性分析2023年1月~2024年1月于安徽医科大学第一附属医院心血管内科行冠状动脉造影的130例2型糖尿病(T2DM)并发冠心病(CHD)患者的临床资料。为了更准确地评估冠脉病变的严重程度,我们根据Gensini评分将入选患者分为两组,低分组(Gensini ≤ 20, n = 64)和高分组(Gensini > 20, n = 66)。通过比较两组患者一般资料及实验室相关指标,探究T2DM合并CHD患者冠脉狭窄程度的影响因素。结果:高分组患者吸烟占比、糖化血红蛋白(HbAlc)、中性粒细胞数(NE)、单核细胞数(MO)、血小板计数(PLT)、血小板压积(PCT)、总蛋白(TP)、球蛋白(GLB)、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、脂蛋白a (Lpa)水平、SII、SIRI指数均高于低分组,且差异均具有统计学意义(P < 0.05)。而低分组的白球比值(AGR)较高(P < 0.05)。值得注意的是,进一步logistic多因素回归分析显示,吸烟及HbA1c、PLT、GLB、CK-MB等指标是冠脉狭窄的独立危险因素(均P < 0.05)。结论:T2DM合并CHD患者冠脉狭窄程度随着吸烟及HbAlc、PLT、GLB、CK-MB水平的升高而加剧,积极戒烟并定期监测上述临床指标,有利于延缓冠脉病变进展。
Abstract: Objective: To identify the potential factors of coronary artery stenosis degree in patients with type 2 diabetes mellitus and coronary heart disease early, so as to optimize the prognosis treatment strategies. Methods: A retrospective analysis was conducted on the clinical data of 130 patients with type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD) who underwent coronary angiography at the Department of Cardiology, First Affiliated Hospital of Anhui Medical University from January 2023 to January 2024. To more accurately assess the severity of coronary artery lesions, we divided the enrolled patients into two groups based on the Gensini score: the low-score group (Gensini ≤ 20, n = 64) and the high-score group (Gensini > 20, n = 66). By comparing baseline and laboratory indices between the two groups, we identified factors associated with the severity of coronary stenosis in T2DM-CHD patients. Results: Patients in the high Gensini score group had higher proportions of smokers and higher levels of HbA1c, NE, MO, PLT, PCT, TP, GLB, CK, CK-MB, Lpa, SII, and SIRI compared with those in the low Gensini score group, with statistical significance (P < 0.05). Conversely, the white-to-red ratio (AGR) in the low-score group was higher (P < 0.05). It is worth noting that further logistic multivariate regression analysis revealed that smoking, as well as blood indicators such as HbA1c, PLT, GLB, and CK-MB, each independently predicted coronary stenosis (all P < 0.05). Conclusion: In patients with T2DM and CHD, the degree of coronary artery stenosis worsens with the increase in smoking and blood indicators such as HbAlc, PLT, GLB, and CK-MB. Actively quitting smoking and regularly monitoring these clinical indicators is beneficial for delaying the progression of coronary artery disease.
文章引用:聂梦梦, 张勇. 吸烟、HbA1c、PLT、GLB、CK-MB与2型糖尿病合并冠心病冠脉狭窄的相关性研究[J]. 临床医学进展, 2025, 15(10): 398-407. https://doi.org/10.12677/acm.2025.15102769

参考文献

[1] Hossain, M.J., Al‐Mamun, M. and Islam, M.R. (2024) Diabetes Mellitus, the Fastest Growing Global Public Health Concern: Early Detection Should Be Focused. Health Science Reports, 7, e2004. [Google Scholar] [CrossRef] [PubMed]
[2] Zhou, Y., Liu, J., Zhao, Z., Zhou, M. and Ng, M. (2025) The National and Provincial Prevalence and Non-Fatal Burdens of Diabetes in China from 2005 to 2023 with Projections of Prevalence to 2050. Military Medical Research, 12, Article No. 28. [Google Scholar] [CrossRef] [PubMed]
[3] Zarkasi, K.A., Abdul Murad, N.A., Ahmad, N., Jamal, R. and Abdullah, N. (2022) Coronary Heart Disease in Type 2 Diabetes Mellitus: Genetic Factors and Their Mechanisms, Gene-Gene, and Gene-Environment Interactions in the Asian Populations. International Journal of Environmental Research and Public Health, 19, Article 647. [Google Scholar] [CrossRef] [PubMed]
[4] Tomic, D., Shaw, J.E. and Magliano, D.J. (2022) The Burden and Risks of Emerging Complications of Diabetes Mellitus. Nature Reviews Endocrinology, 18, 525-539. [Google Scholar] [CrossRef] [PubMed]
[5] Wong, N.D. and Sattar, N. (2023) Cardiovascular Risk in Diabetes Mellitus: Epidemiology, Assessment and Prevention. Nature Reviews Cardiology, 20, 685-695. [Google Scholar] [CrossRef] [PubMed]
[6] Kaur, R., Kaur, M. and Singh, J. (2018) Endothelial Dysfunction and Platelet Hyperactivity in Type 2 Diabetes Mellitus: Molecular Insights and Therapeutic Strategies. Cardiovascular Diabetology, 17, Article No. 121. [Google Scholar] [CrossRef] [PubMed]
[7] Weinberg Sibony, R., Segev, O., Dor, S. and Raz, I. (2024) Overview of Oxidative Stress and Inflammation in Diabetes. Journal of Diabetes, 16, e70014. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, K., Zheng, Y., Wu, T., Ma, Y. and Xie, X. (2022) Predictive Value of Gensini Score in the Long-Term Outcomes of Patients with Coronary Artery Disease Who Underwent PCI. Frontiers in Cardiovascular Medicine, 8, Article ID: 778615. [Google Scholar] [CrossRef] [PubMed]
[9] 黄心怡, 杨旭东, 石士奎. FAI及CT-FFR联合Gensini评分对ACS经皮冠状动脉介入治疗术后MACE发生的预测价值[J]. 中国CT和MRI杂志, 2025, 23(4): 90-92.
[10] 仲艳华, 桑盛敏, 丁宏胜. 血清尿酸联合Gensini积分预测急性ST段抬高型心肌梗死患者预后的价值[J]. 实用临床医药杂志, 2021, 25(23): 82-85.
[11] 中国2型糖尿病防治指南(2020年版) (下) [J]. 中国实用内科杂志, 2021, 41(9): 757-784.
[12] Saraste, A. and Knuuti, J. (2020) ESC 2019 Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes: Recommendations for Cardiovascular Imaging. Herz, 45, 409-420. [Google Scholar] [CrossRef] [PubMed]
[13] Rampidis, G.P., Benetos, G., Benz, D.C., Giannopoulos, A.A. and Buechel, R.R. (2019) A Guide for Gensini Score calculation. Atherosclerosis, 287, 181-183. [Google Scholar] [CrossRef] [PubMed]
[14] Liang, F. and Wang, Y. (2021) Coronary Heart Disease and Atrial Fibrillation: A Vicious Cycle. American Journal of Physiology-Heart and Circulatory Physiology, 320, H1-H12. [Google Scholar] [CrossRef] [PubMed]
[15] Tao, S., Yu, L., Li, J., Huang, L., Xue, T., Yang, D., et al. (2024) Multiple Triglyceride-Derived Metabolic Indices and Incident Cardiovascular Outcomes in Patients with Type 2 Diabetes and Coronary Heart Disease. Cardiovascular Diabetology, 23, Article No. 359. [Google Scholar] [CrossRef] [PubMed]
[16] 舒荣文, 孔庆军, 钟勇, 等. 冠状动脉造影金标准与临床常规诊断冠心病差异性比较研究[J]. 海军医学杂志, 2015, 36(4): 311-314.
[17] Naser, A. (2024) The Gensini Score System Is a Useful Tool in Assessing the Burden and Severity of Coronary Artery Atherosclerotic Lesions [Letter]. International Journal of General Medicine, 17, 4227-4228. [Google Scholar] [CrossRef] [PubMed]
[18] 雷文慧, 何诗琪, 王豪, 等. 中老年男性吸烟状况与心血管疾病发生风险的关联性[J]. 中华疾病控制杂志, 2019, 23(7): 774-779.
[19] Ishida, M., Sakai, C., Kobayashi, Y. and Ishida, T. (2024) Cigarette Smoking and Atherosclerotic Cardiovascular Disease. Journal of Atherosclerosis and Thrombosis, 31, 189-200. [Google Scholar] [CrossRef] [PubMed]
[20] 程宝山, 梁丰, 王春苗, 等. 冠心病合并2型糖尿病患者糖化血红蛋白与冠脉病变严重程度的关系[J]. 现代医学, 2022, 50(3): 290-294.
[21] Sartore, G., Ragazzi, E., Caprino, R. and Lapolla, A. (2023) Long-Term Hba1c Variability and Macro-/Micro-Vascular Complications in Type 2 Diabetes Mellitus: A Meta-Analysis Update. Acta Diabetologica, 60, 721-738. [Google Scholar] [CrossRef] [PubMed]
[22] Lee, I., Agrawal, A., Ghandour, S., Suarez, S., Patel, S., Young, E., et al. (2025) The Influence of Diabetes on Thrombotic Profiles and Outcomes on Patients with Peripheral Artery Disease. Annals of Vascular Surgery, 110, 246-259. [Google Scholar] [CrossRef] [PubMed]
[23] Khodadi, E. (2020) Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules. Cardiovascular Toxicology, 20, 1-10. [Google Scholar] [CrossRef] [PubMed]
[24] von Hundelshausen, P. and Weber, C. (2007) Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease. Circulation Research, 100, 27-40. [Google Scholar] [CrossRef] [PubMed]
[25] Uysal, H.B., Dağlı, B., Akgüllü, C., Avcil, M., Zencir, C., Ayhan, M., et al. (2016) Blood Count Parameters Can Predict the Severity of Coronary Artery Disease. The Korean Journal of Internal Medicine, 31, 1093-1100. [Google Scholar] [CrossRef] [PubMed]
[26] Wang, H., Li, H., Wang, Y., Zhao, C., Tian, Q., Wang, Q., et al. (2023) Hematological Parameters and Early-Onset Coronary Artery Disease: A Retrospective Case-Control Study Based on 3366 Participants. Therapeutic Advances in Chronic Disease, 14, Article 374191246. [Google Scholar] [CrossRef] [PubMed]
[27] Johny, E., Bhaskar, P., Alam, M.J., Kuladhipati, I., Das, R. and Adela, R. (2021) Platelet Mediated Inflammation in Coronary Artery Disease with Type 2 Diabetes Patients. Journal of Inflammation Research, 14, 5131-5147. [Google Scholar] [CrossRef] [PubMed]
[28] Chou, Y., Chen, H., Wu, I., Su, F., Li, W., Hsu, H., et al. (2022) Higher Platelet Count, Even within Normal Range, Is Associated with Increased Arterial Stiffness in Young and Middle-Aged Adults. Aging, 14, 8061-8076. [Google Scholar] [CrossRef] [PubMed]
[29] Falcinelli, E., Giannini, S., Boschetti, E. and Gresele, P. (2007) Platelets Release Active Matrix Metalloproteinase‐2 in Vivo in Humans at a Site of Vascular Injury: Lack of Inhibition by Aspirin. British Journal of Haematology, 138, 221-230. [Google Scholar] [CrossRef] [PubMed]
[30] Iannarelli, N.J., MacNeil, A.J., Dempster, K.S., Wade, T.J. and O’Leary, D.D. (2021) Serum MMP-3 and Its Association with Central Arterial Stiffness among Young Adults Is Moderated by Smoking and BMI. Physiological Reports, 9, e14920. [Google Scholar] [CrossRef] [PubMed]
[31] Hsieh, Y., Tsai, S., Kor, C. and Chiu, P. (2023) Serum Globulin Is a Novel Predictor of Mortality in Patients Undergoing Peritoneal Dialysis. Scientific Reports, 13, Article No. 1139. [Google Scholar] [CrossRef] [PubMed]
[32] Yang, S., Zhou, Y., Xu, D., Dong, Y., Tang, H., Jing, P., et al. (2025) The Associations between the FAGR and All-Cause and Cardiovascular Mortality in Patients with Stemi. Scientific Reports, 15, Article No. 9237. [Google Scholar] [CrossRef] [PubMed]
[33] Wang, M., Liu, J., Ma, C., Wang, W., Liu, X., Li, Y., et al. (2012) Synergistic Association of Serum Albumin and Globulin with Coronary Heart Disease. Journal of Atherosclerosis and Thrombosis, 19, 619-632. [Google Scholar] [CrossRef] [PubMed]
[34] Pan, C., Wang, T., Yin, R., Tang, X. and Hu, C. (2025) Coronary Imaging Characteristics and Risk Factors in Patients with Type 2 Diabetes Mellitus with Coronary Heart Disease Complication. World Journal of Diabetes, 16, Article 99151. [Google Scholar] [CrossRef] [PubMed]
[35] Lee, J., Choi, Y., Chung, W., Kwon, A., Park, C. and Lee, M. (2017) High Coronary Calcium Score and Post-Procedural CK-MB Are Noninvasive Predictors of Coronary Stent Restenosis. Clinical Interventions in Aging, 12, 399-404. [Google Scholar] [CrossRef] [PubMed]
[36] 李佳星, 杨保同, 刘亚林. 血清CK-MB、Hcy、BNP与急性心肌梗死严重程度的相关性分析及临床意义[J]. 实用心电学杂志, 2024, 33(2): 128-132.
[37] Duan, D., Li, H., Chai, S., Zhang, L., Fan, T., Hu, Z., et al. (2024) The Relationship between Cardiac Oxidative Stress, Inflammatory Cytokine Response, Cardiac Pump Function, and Prognosis Post-Myocardial Infarction. Scientific Reports, 14, Article No. 8985. [Google Scholar] [CrossRef] [PubMed]
[38] Liu, Y., Wu, P., Xu, X., Shen, T., Wang, X., Liu, Y., et al. (2023) C1q/TNF-Related Protein 3 Alleviates Heart Failure via Attenuation of Oxidative Stress in Myocardial Infarction Rats. Peptides, 163, Article 170980. [Google Scholar] [CrossRef] [PubMed]
[39] Averna, M. and Cefalù, A.B. (2025) Lp(a): The New Marker of High Cardiovascular Risk. Nutrition, Metabolism and Cardiovascular Diseases, 35, Article 103845. [Google Scholar] [CrossRef] [PubMed]
[40] Kamstrup, P.R. (2009) Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction. JAMA, 301, 2331-2339. [Google Scholar] [CrossRef] [PubMed]
[41] Han, K., Shi, D., Yang, L., Wang, Z., Li, Y., Gao, F., et al. (2022) Prognostic Value of Systemic Inflammatory Response Index in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Annals of Medicine, 54, 1667-1677. [Google Scholar] [CrossRef] [PubMed]
[42] He, T., Luo, Y., Wan, J., Hou, L., Su, K., Zhao, J., et al. (2024) Analysis of the Correlation between the Systemic Inflammatory Response Index and the Severity of Coronary Vasculopathy. Biomolecules and Biomedicine, 24, 1726-1734. [Google Scholar] [CrossRef] [PubMed]
[43] Shen, C., Wang, J. and Tu, S. (2022) Effects of Serum LDL-C, CysC, and D-D in Patients with Coronary Atherosclerotic Heart Disease. Computational Intelligence and Neuroscience, 2022, Article ID: 5771960. [Google Scholar] [CrossRef] [PubMed]